Courtesy of Benzinga.
In a report published Monday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Baxter International (NYSE: BAX), but lowered the price target from $80.00 to $75.00.
In the report, Morgan Stanley noted, “HyQ approval and 855 data have derisked the story, and we see value creation through the spin. However, consensus numbers still need to come down, despite our view that Advate estimates are achievable. On lower numbers, our price target falls to $75 from $80, and we remain Equal-Weight.”
Baxter International closed on Friday at $71.25.
Latest Ratings for BAX
Date | Firm | Action | From | To |
---|---|---|---|---|
Oct 2014 | Morgan Stanley | Maintains | Equal-weight | |
Oct 2014 | Bank of America | Maintains | Buy | |
Sep 2014 | JP Morgan | Maintains | Neutral |
View More Analyst Ratings for BAX
View the Latest Analyst Ratings
Posted-In: David R. Lewis Morgan StanleyAnalyst Color Price Target Analyst Ratings